GABRIEL MCGUIRE: Open Payments
NPI 1790506780 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 58 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $60 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $171 |
| Corcept Therapeutics | 5 | $140 |
| Lilly USA, LLC | 12 | $120 |
| PFIZER INC. | 6 | $98 |
| Novo Nordisk Inc | 6 | $97 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: Korlym, MOUNJARO, QULIPTA, ELIQUIS, TRELEGY ELLIPTA, VOQUEZNA, UBRELVY, Wegovy.
Industry payments across TX — which companies pay providers there.
